Britain’s National Health Service (NHS) has announced that it will not cover Eli Lilly’s new Alzheimer’s drug, donanemab.

We recently published a list of 10 Best Stocks to Buy According to Billionaire Ken Fisher. In this article, we are going to ...

Headquartered in Indianapolis, Indiana, Eli Lilly and Company (LLY) is a leading biopharmaceutical firm with a market cap of ...

Seeking ways to improve the safety of anti-amyloid antibodies, John Sims of Eli Lilly & Company presented a simple option to do so for donanemab at this year’s Clinical Trials on Alzheimer’s Disease ...

We recently compiled a list of the 10 Best Low Volatility Stocks to Invest in Now. In this article, we are going to take a ...

Britain’s National Health Service (NHS) has announced that it will not cover Eli Lilly’s new Alzheimer’s drug, donanemab. Initially, the NHS was expected to approve the drug this week ...

Being started on a smaller dose of the approved early Alzheimer’s therapy Kisunla was found to reduce the risk of ARIA-E on imaging scans.

Brain diagnostics company Amprion recently closed $6 million from a $15 million total Series B financing round to expand the company's commercial reach ...

1 Donanemab is approved under the brand name Kisunla™ in the United States, Japan, Great Britain and other countries. These data were presented at Eli Lilly and Company (NYSE: LLY) announced ...

1 Donanemab is approved under the brand name Kisunla™ in the United States, Japan, Great Britain and other countries. These data were presented at Eli Lilly and Company (NYSE: LLY) announced ...

Cassava then released the altered data in a press release and investor deck, which led the SEC to allege that the company and ...

INDIANAPOLIS - Eli Lilly and Company (NYSE:LLY) announced a fourth-quarter dividend of $1.30 per share on its outstanding common stock. The declared dividend is ...